Factors associated with sustained virologic response 1 year after treatment with peginterferon alfa-2A (40KD) (PEGASYS (R)) monotherapy for HBEAG-negative chronic hepatitis B

Simple item page
dc.contributor.authorPatrick, Marcellin
dc.contributor.authorFerruccio, Bonino
dc.contributor.authorLau, Grace
dc.contributor.authorPatrizia, Farci
dc.contributor.authorYurdaydın, Cihan
dc.contributor.authorPiratvisuth, Teerha
dc.contributor.authorJin, Rui
dc.contributor.authorHadziyannis, Stephanos
dc.contributor.authorLu, Zhi-Meng
dc.contributor.authorPopescu, Matei
dc.contributor.buuauthorGürel, Selim
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Gastroenteroloji Anabilim Dalı.tr_TR
dc.date.accessioned2022-03-11T07:50:53Z
dc.date.available2022-03-11T07:50:53Z
dc.date.issued2005-10
dc.descriptionBu çalışma, 11-15 Kasım 2005 tarihleri arasında San Francisco[Californiya]’da düzenlenen 56. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases’da bildiri olarak sunulmuştur.tr_TR
dc.description.sponsorshipAmer Assoc Study Liver Disen_US
dc.identifier.citationMarcellin, P. vd. (2005). "Factors associated with sustained virologic response 1 year after treatment with peginterferon alfa-2A (40KD) (PEGASYS (R)) monotherapy for HBEAG-negative chronic hepatitis B". Hepatology, 42(4), Supplement 1, 580A-580A.en_US
dc.identifier.endpage580Atr_TR
dc.identifier.issn0270-9139
dc.identifier.issue4tr_TR
dc.identifier.startpage580Atr_TR
dc.identifier.urihttp://hdl.handle.net/11452/24946
dc.identifier.volume42tr_TR
dc.identifier.wos000232480302034tr_TR
dc.indexed.wosSCIEen_US
dc.indexed.wosCPCISen_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.collaborationYurt içitr_TR
dc.relation.collaborationYurt dışıtr_TR
dc.relation.collaborationSanayitr_TR
dc.relation.journalHepatologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararasıtr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectGastroenterology & hepatologyen_US
dc.subject.wosGastroenterology & hepatologyen_US
dc.titleFactors associated with sustained virologic response 1 year after treatment with peginterferon alfa-2A (40KD) (PEGASYS (R)) monotherapy for HBEAG-negative chronic hepatitis Ben_US
dc.typeMeeting Abstract
dc.wos.quartileQ1en_US

Files

License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Web of Science